These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride on gastric mucosal blood flow. Hoshina K; Okada N; Inoue K; Yamamoto M; Saito N; Takeshita T; Naruchi T Arzneimittelforschung; 1987 Nov; 37(11):1284-9. PubMed ID: 3440037 [TBL] [Abstract][Full Text] [Related]
3. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl] propionic acid hydrochloride on gastric mucosa directly from the lumen. Hoshina K; Tanabe H; Yamazaki N; Yamamoto M; Ohba T; Takeshita T; Naruchi T Arzneimittelforschung; 1987 Nov; 37(11):1289-95. PubMed ID: 3440038 [TBL] [Abstract][Full Text] [Related]
4. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers. Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535 [TBL] [Abstract][Full Text] [Related]
5. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats. Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336 [TBL] [Abstract][Full Text] [Related]
6. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers. Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415 [TBL] [Abstract][Full Text] [Related]
7. Anti-ulcer effect of 1,6-dihydro-2-[2-(2-methylpropoxy) anilino]-6-oxo-5-pyrimidinecarboxylic acid on experimental gastric ulcers in rats. Ishizuka Y; Kamisaki T; Matsuda M; Shimazaki I; Kawashima M; Yaginuma H; Terashima K; Sato M Arzneimittelforschung; 1994 Apr; 44(4):509-13. PubMed ID: 8011005 [TBL] [Abstract][Full Text] [Related]
8. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals. Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106 [TBL] [Abstract][Full Text] [Related]
9. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride on gastric mucosal barrier. Hoshina K; Yamazaki N; Takeshita T; Naruchi T Arzneimittelforschung; 1987 Oct; 37(10):1154-8. PubMed ID: 3435587 [TBL] [Abstract][Full Text] [Related]
10. Gastric anti-ulcer and cytoprotective properties of 2-(3,4-dimethoxyphenyl)-5-methyl-thiazolidine-4-one in rat experimental ulcers. Matsuo Y; Kuwayama H; Itoh H; Seki A; Fukuda S; Kawasaki T; Hotta T; Ohsaka Y; Komatsu K Arzneimittelforschung; 1986 Aug; 36(8):1236-40. PubMed ID: 3778561 [TBL] [Abstract][Full Text] [Related]
11. Healing effects of heparin on acetic acid-induced gastric ulcers in rats. Li Y; Mei QB; Cho CH Chin Med J (Engl); 1998 Jan; 111(1):12-6. PubMed ID: 10322645 [TBL] [Abstract][Full Text] [Related]
12. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation. Tarutani M; Sakuma H; Shiratsuchi K; Mieda M Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875 [TBL] [Abstract][Full Text] [Related]
13. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity. Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413 [TBL] [Abstract][Full Text] [Related]
14. Effects of indomethacin and cold-stress on gastric acid secretion and ulceration. The effects of anti-acid secretory agents in rats. Arai I; Hirose H; Usuki C; Muramatsu M; Aihara H Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):313-27. PubMed ID: 3671883 [TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor-alpha agonist (bezafibrate) on gastric secretion and gastric cytoprotection in rats. Pathak R; Asad M; Hrishikeshavan HJ; Prasad S Fundam Clin Pharmacol; 2007 Jun; 21(3):291-6. PubMed ID: 17521298 [TBL] [Abstract][Full Text] [Related]
16. Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats. Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S Acta Pharmacol Sin; 2001 Jun; 22(6):488-92. PubMed ID: 11747752 [TBL] [Abstract][Full Text] [Related]
17. Effect of 1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarboxylic acid on gastric mucosal defensive factors and gastric secretion in rats. Ishizuka Y; Kamisaki T; Okamoto N; Matsuda M; Shimazaki I; Kimura I; Kamiya A; Kataoka M; Kawashima M; Terashima K Arzneimittelforschung; 1994 May; 44(5):620-6. PubMed ID: 8024635 [TBL] [Abstract][Full Text] [Related]
18. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity. DiJoseph JF; Eash JR; Mir GN J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297 [TBL] [Abstract][Full Text] [Related]
19. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178 [TBL] [Abstract][Full Text] [Related]
20. Effect and mechanism of sucralfate on healing of acetic acid-induced gastric ulcers in rats. Ogihara Y; Okabe S J Physiol Pharmacol; 1993 Jun; 44(2):109-18. PubMed ID: 8358048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]